SCHEMBL409370

SCHEMBL409370

CCN(c1ccccc1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.57
MAPT P10636 1/20 0.52
CRHBP P24387 1/20 0.52
CRHR2 Q13324 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
TSHR P16473 4/20 0.50
ALDH1A1 P00352 2/20 0.50
GLA P06280 1/20 0.50
KDM4C Q9H3R0 1/20 0.46
APAF1 O14727 1/20 0.46
CASP3 P42574 1/20 0.46
CASP6 P55212 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
DHFR P00374 2/20 0.43
CHRM2 P08172 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
CHRM1 P11229 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567347 1.00 NR3C2 (0.57) NR3C2MAPTCRHBPCRHR2NPSR1
Bromide SCHEMBL6737911 0.97 NR3C2 (0.55) NR3C2MAPTCRHBPCRHR2NPSR1
SCHEMBL7149333 0.97 NR3C2 (0.60) NR3C2MAPTCRHBPCRHR2NPSR1
Iodide SCHEMBL31634397 0.97 NR3C2 (0.55) NR3C2MAPTCRHBPCRHR2NPSR1
Hydrochloric Acid SCHEMBL27464725 0.97 NR3C2 (0.55) NR3C2MAPTCRHBPCRHR2NPSR1
SCHEMBL16408145 0.92 NR3C2 (0.56) NR3C2MAPTCRHBPCRHR2NPSR1
SCHEMBL28902453 0.92 NR3C2 (0.52) NR3C2MAPTCRHBPCRHR2NPSR1
SCHEMBL6932587 0.92 NR3C2 (0.52) NR3C2MAPTCRHBPCRHR2NPSR1
SCHEMBL3368539 0.90 NR3C2 (0.55) NR3C2MAPTCRHBPCRHR2NPSR1
SCHEMBL20160922 0.88 NR3C2 (0.53) NR3C2MAPTCRHBPCRHR2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116970107-A Catalyst combination and method for preparing poly alpha-olefin synthetic oil by using same 万华化学集团股份有限公司 2023-10-31 CN claimed
CN-112473741-B Ethylene oligomerization catalyst system and preparation method and application thereof 杭州小菱科技有限公司 2023-09-01 CN claimed
CN-112473738-B Ethylene oligomerization catalyst system and preparation method and application thereof 杭州小菱科技有限公司 2023-08-15 CN claimed
CN-115698118-A Liquid formulations comprising aldehyde scavengers 佛莱恩股份公司 2023-02-03 CN claimed
CN-112920874-B Preparation method of polyolefin synthetic oil 亚培烯科技(杭州)有限公司 2023-01-10 CN claimed
CN-115449364-A Lead-free double perovskite luminescent material and preparation method thereof 苏州大学 2022-12-09 CN claimed
CN-114573606-A Preparation method and application of photocuring epoxy polyimide 中山大学 2022-06-03 CN claimed
US-11161811-B2 Process for preparing Mannich base quaternary ammonium salt high-temperature resistant corrosion inhibitor and applications thereof SOUTHWEST PETROLEUM UNIVERSITY (CN) 2021-11-02 US claimed
CN-113227117-A Peptoid compound and detection chip with peptoid compound coupled to surface 京东方科技集团股份有限公司 2021-08-06 CN claimed
CN-112920874-A Preparation method of polyolefin synthetic oil 亚培烯科技(杭州)有限公司 2021-06-08 CN claimed
CN-1077960-A HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1993-11-03 CN claimed
CN-1054773-A HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1991-09-25 CN claimed
US-4954665-A ETHANOL FROM METHANOL AND SYSTHESIS GAS UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) 1990-09-04 US claimed
CN-1040203-A ANTI-AGGREGATORY PEPTIDES SMITHKLINE BECKMAN CORP (US) 1990-03-07 CN claimed
EP-0093511-B1 METHOD FOR PRODUCING AND OPTICALLY ACTIVE 2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-09-24 EP claimed
US-4542235-A Method for producing an optically active 2,2-dimethylcyclopropanecarboxylic acid SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-09-17 US claimed
EP-0093511-A1 Method for producing and optically active 2,2-dimethylcyclopropanecarboxylic acid SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-11-09 EP claimed
EP-0020138-B1 N-(2-AMINO-3-ETHYL-ALPHA-METHYLBENZYLIDENE)-2,6-DIETHYLANILINE AND ITS PREPARATION; ANTIOXIDANT ADDITIVE MIXTURES INCLUDING SAID COMPOUND; THE USE OF SAID COMPOUND, SAID ADDITIVE MIXTURES AND CERTAIN ALKYLATED ANILINES AS ANTIOXIDANTS FOR ORGANIC MATERIALS; AND ORGANIC MATERIALS AFFORDED ANTIOXIDANT PROTECTION AS AFORESAID ETHYL CORPORATION (US) 1983-06-22 EP claimed
US-4269720-A N-(2-AMINO-3-ETHYL-ALPHA-METHYLBENZYLIDENE)-2,6-DIETHYL ANILINE ETHYL CORPORATION (US) 1981-05-26 US claimed
EP-0020138-A2 N-(2-amino-3-ethyl-alpha-methylbenzylidene)-2,6-diethylaniline and its preparation; antioxidant additive mixtures including said compound; the use of said compound, said additive mixtures and certain alkylated anilines as antioxidants for organic materials; and organic materials afforded antioxidant protection as aforesaid ETHYL CORPORATION (US) 1980-12-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161811-B2 Process for preparing Mannich base quaternary ammonium salt high-temperature resistant corrosion inhibitor and applications thereof DDC, TYR, ABL1 NR3C2 1013/4885MAPT 1738/4885CRHBP 3047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.